| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.06 |